NWS
84
20
NTRS
64
-5
HRB
61
9
PPL
69
2
CCI
30
2
HPE
50
-16
BA
45
-3
AMAT
54
-4
HST
37
-2
KEY
58
-2
MSFT
65
-3
LNC
52
9
PFE
45
16
K
59
6
ORLY
57
4
KO
52
-8
AZO
63
-2
ADP
74
-2
VRTX
45
2
GOOGL
58
-4
NWS
84
20
NTRS
64
-5
HRB
61
9
PPL
69
2
CCI
30
2
HPE
50
-16
BA
45
-3
AMAT
54
-4
HST
37
-2
KEY
58
-2
MSFT
65
-3
LNC
52
9
PFE
45
16
K
59
6
ORLY
57
4
KO
52
-8
AZO
63
-2
ADP
74
-2
VRTX
45
2
GOOGL
58
-4
Financhill
Back

Teva Pharmaceutical Industries Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
45

TEVA
Teva Pharmaceutical Industries

Last Price:
$16.96
Seasonality Move:
0.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Teva Pharmaceutical Industries Stock Forecast

  • Over the next 52 weeks, Teva Pharmaceutical Industries has on average historically risen by 14.2% based on the past 43 years of stock performance.
  • Teva Pharmaceutical Industries has risen higher in 27 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.79%
  • Is Teva Pharmaceutical Industries Stock Undervalued?
    The current Teva Pharmaceutical Industries [TEVA] share price is $16.96. The Score for TEVA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • TEVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Teva Pharmaceutical Industries Stock Go Up Next Year?

  • Over the next 52 weeks, Teva Pharmaceutical Industries has on average historically risen by 14.2% based on the past 43 years of stock performance.

Teva Pharmaceutical Industries Stock Rating

Sell
45
Teva Pharmaceutical Industries (TEVA) is a Sell

Is Teva Pharmaceutical Industries overpriced?

  • Teva Pharmaceutical Industries has risen higher in 27 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.79%

Teva Pharmaceutical Industries Stock Price History

Is TEVA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TEVA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Israel
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
tevapharm.com

52-Week Data

52-Week High:
22.80
52-Week Low:
12.47

Prediction Charts

Market Cap:
19.5B
Price in USD:
16.96
Volume:
6.5M
Beta:
0.59

Technical Analysis

SMA50:
15.56
SMA100:
17.16
SMA200:
17.54
52-Wk Change:
1.19%

Stock Predictions

  • Is Teva Pharmaceutical Industries stock public?
    Yes, Teva Pharmaceutical Industries is a publicly traded company.
  • What is the Teva Pharmaceutical Industries stock quote today?
    The Teva Pharmaceutical Industries stock price is 16.96 USD today.
  • How to buy Teva Pharmaceutical Industries stock online?
    You can buy Teva Pharmaceutical Industries shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 16.43 16.12 16.71 16.12
May-7 16.69 17.60 17.69 16.60
May-8 17.52 18.07 18.30 17.50
May-9 18.20 16.93 18.25 16.89
May-12 17.25 17.96 18.07 16.90
May-13 17.77 17.48 17.89 17.23
May-14 17.47 16.89 17.50 16.68
May-15 16.85 16.87 17.10 16.81
May-16 17.12 16.94 17.22 16.75
May-19 16.93 17.02 17.06 16.75
May-20 17.11 16.78 17.20 16.71
May-21 16.68 16.55 16.88 16.39
May-22 16.47 16.94 17.08 16.39
May-23 16.46 16.96 17.08 16.55

Teva Pharmaceutical Industries Earnings

Teva Pharmaceutical Industries Earnings Report: Per Share Teva Pharmaceutical Industries Earnings Q1 Q2 Q3 and Q4 last year and next year.

Teva Pharmaceutical Industries Forecast Revenue Growth

Teva Pharmaceutical Industries Stock Analysis: Historical quarterly revenues per share for Teva Pharmaceutical Industries and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.08 per share, and an increase next year of $0.21 per share.

* Teva Pharmaceutical Industries stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.